今日の臨床サポート 今日の臨床サポート
関連論文:
img  22:  Quality of life and stigmatization profile in a cohort of vitiligo patients and effect of the use of camouflage.
 
著者: K Ongenae, L Dierckxsens, L Brochez, N van Geel, J M Naeyaert
雑誌名: Dermatology. 2005;210(4):279-85. doi: 10.1159/000084751.
Abstract/Text BACKGROUND: Few studies have paid attention to the effects of treatment interventions on the psychosocial consequences of vitiligo.
OBJECTIVES: To quantify and analyse the psychosocial benefit of the use of camouflage in vitiligo patients.
PATIENTS AND METHODS: 78 vitiligo patients completed the Dermatology Life Quality Index (DLQI) and an adapted stigmatization questionnaire, and 62 of them completed the DLQI after at least a 1-month use of camouflage.
RESULTS: The initial mean overall DLQI score (n = 78) is 6.9 (SD 5.6). The mean global stigmatization score is 38%. Disease extent and disease severity are strong predictors of the DLQI (p < 0.0001). Vitiligo on the face/head/neck substantially affects the DLQI, independently of degree of involvement. The mean DLQI score before and after use of camouflage (n = 62) is 7.3 (SD 5.6) and 5.9 (SD 5.2; p = 0.006). Mainly the high-scoring items 'feelings of embarrassment and self consciousness' and 'choice of clothing' improve. Predictors of improvement are higher DLQI scores (p = 0.0005) and higher total severity scores (p = 0.03).
CONCLUSIONS: Camouflage can be recommended, particularly in patients with higher DLQI scores or self-assessed disease severity. Patients with minor involvement of the face benefit from camouflage.

2005 S. Karger AG, Basel
PMID 15942213  Dermatology. 2005;210(4):279-85. doi: 10.1159/000084751.
戻る

さらなるご利用にはご登録が必要です。

こちらよりご契約または優待日間無料トライアルお申込みをお願いします。

(※トライアルご登録は1名様につき、一度となります)


ご契約の場合はご招待された方だけのご優待特典があります。

以下の優待コードを入力いただくと、

契約期間が通常12ヵ月のところ、14ヵ月ご利用いただけます。

優待コード: (利用期限:まで)

ご契約はこちらから